ENT Devices Market Size to Reach $23.01 Billion by 2022: Grand View Research, Inc.

SAN FRANCISCO, July 30, 2015 /PRNewswire/ --

Global ENT (Ear, Nose, And Throat) devices market is expected to reach USD 23.01 million in 2022, according to a new study by Grand View Research, Inc. Growing base of geriatric population, increasing prevalence of ear, nose, and throat related traumas and infections, and rising level of awareness among target customer base are expected serve this market as high impact rendering drivers over the forecast period. According to estimates published by the WHO, 15% of adult population and 33% of geriatric population globally suffer from hearing disorders. Moreover, 13,560 new cases are estimated to be registered in 2015 according to the National Cancer Institute. Technological advancements and the use of user-friendly materials in product development are expected to further boost the growth of this ENT devices industry. For instance, the use of thermoplastic material for the development of custom/cut size external nasal splints is likely to gain penetration over the next seven years.

     (Logo: http://photos.prnewswire.com/prnh/20150105/723757)

Browse full research report with TOC on "ENT (Ear, Nose, And Throat) Devices Market Analysis By Product (Diagnostic, Rigid Endoscopes, Robot Assisted Endoscope, Hearing Screening, Surgical Devices, Radiofrequency Handpieces, Powered Surgical Instrument, ENT Hand Instruments Hearing Aids, Behind-the-Ear Aids, Cochlear Implants, Bone Anchored Hearing System, Voice Prosthesis Devices, Nasal Splints) And Segment Forecasts To 2022" at: http://www.grandviewresearch.com/industry-analysis/ent-ear-nose-and-throat-devices-market  

Valued at over 5.0 billion, hearing aids were the largest product segment of the market in 2014. Growing target population, considerably high market usage, and high accessibility are amongst some key factors accounting for its large market share. On the other hand, hearing implants and voice prosthesis are expected to witness rapid growth over the forecast period owing to the introduction of technological advancements aimed to increase patient compliance and overcome social stigmas.

Further key findings from the study suggest: 

• Cochlear implant was also one of the largest product segments in 2014. The introduction of customizable implants is expected to drive segment growth over the forecast period. Introduction of technological advancements such as microchip technology is also likely to boost usage rates.
• North America dominated the overall market in terms of revenue share in 2014 at over 35%, majorly due to the presence of favorable government initiatives, sophisticated healthcare infrastructure, and user awareness levels
• The Asia Pacific ENT devices market is expected to witness rapid growth due to, rapidly improving healthcare infrastructure, presence of favorable government policies, clinical advancements in product development and rising healthcare expenditure levels
• Key players of this industry are revising product line by introducing novel technologies such as Soundbridge by MED-EL and HiQ+ series of bipolar endoscopes by Olympus medical systems. Some key players operating in this market include GN ReSound A/S, Sonova Holding AG, Starkey Laboratories Inc., Cochlear Limited, William Demant Holding A/S, Siemens Healthcare, Widex A/S, Rion Co., Ltd., Welch Allyn, and Atos Medical AB.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices  

For the purpose of this study, Grand View Research has segmented the ENT Devices Market on the basis of product and region: 

• Global ENT Devices Product Outlook (Revenue, USD Million 2012- 2022) 
  • Diagnostic Ear, Nose, and Throat (ENT) Devices
    • Rigid Endoscopes
      • Rhinoscopes
      • Laryngoscopes
      • Otological Endoscopes
    • Flexible Endoscopes
    • Robot Assisted Endoscope
    • Hearing Screening Device
  • Surgical Ear, Nose, And Throat (ENT) Devices
    • Radiofrequency Handpieces
    • Powered Surgical Instrument
    • Otological Drill Burrs
    • ENT Hand Instruments
    • Tympanostomy Tubes
    • Sinus Dilation Devices
    • Nasal Packing Devices
  • Hearing Aids Ear, Nose, And Throat (ENT) Devices
    • Behind-the-Ear (BTE) aids
    • In-The-Ear aids
    • Receiver-In-The-Ear (RITE)
    • Canal hearing aids ITC, CIC and IIC
  • Hearing Implants Ear, Nose, And Throat (ENT) Devices
    • Auditory Brainstem Implants
    • Cochlear Implants
    • Middle Ear Implants
    • Bone Anchored Hearing System
  • Nasal Splints Ear, Nose, And Throat (ENT) Devices
    • Internal Nasal Splints
    • External Nasal Splints 
• ENT Devices Regional Outlook (Revenue, USD Million, 2012 - 2022) 
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa (MEA)
  • South Africa

Browse related reports by Grand View Research: 

• Craniomaxillofacial Devices Market - http://www.grandviewresearch.com/industry-analysis/craniomaxillofacial-devices-market  

• Diabetic Retinopathy Market - http://www.grandviewresearch.com/industry-analysis/diabetic-retinopathy-market                                          

About Grand View Research 

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: http://www.grandviewresearch.com
Read Our Blogs - dniamericas.org, ni2014.org, terrapass.org  

SOURCE Grand View Research, Inc.